Advances in small-molecule drug discovery for triple-negative breast cancer.
about
Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers.Small-molecule RL71-triggered excessive autophagic cell death as a potential therapeutic strategy in triple-negative breast cancer.Sphingosylphosphorylcholine Induces Thrombospondin-1 Secretion in MCF10A Cells via ERK2.Silence of α1-Antitrypsin Inhibits Migration and Proliferation of Triple Negative Breast Cancer Cells
P2860
Advances in small-molecule drug discovery for triple-negative breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Advances in small-molecule drug discovery for triple-negative breast cancer.
@ast
Advances in small-molecule drug discovery for triple-negative breast cancer.
@en
type
label
Advances in small-molecule drug discovery for triple-negative breast cancer.
@ast
Advances in small-molecule drug discovery for triple-negative breast cancer.
@en
prefLabel
Advances in small-molecule drug discovery for triple-negative breast cancer.
@ast
Advances in small-molecule drug discovery for triple-negative breast cancer.
@en
P2093
P2860
P356
P1476
Advances in small-molecule drug discovery for triple-negative breast cancer
@en
P2093
Andrew D Westwell
Hoi Ping Weeks
María Sánchez Peris
P2860
P304
P356
10.4155/FMC.15.129
P577
2015-10-23T00:00:00Z